Thursday, 14 May 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 14 May 2026
News

Blockbuster about to get bigger?

 Posted 14 May 2026 AM

An even bigger market for Lilly's blockbuster Mounjaro is emerging with newly published study results showing that continuing to take the drug kept the kilos off long term.

It expands use of the drug beyond initial weight loss to maintenance and answers critics who have warned weight returns once patients stop using the medication.

To see the whole article, please login

Popular

Pharma crowned 'Most Impactful'
Shake-up hits 2025 top-earners list
Aussie expat scores top global job
Look who's won a Board seat
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home